PALO ALTO, Calif., Sept. 21, 2022 /PRNewswire/ -- Norwest Venture Partners, a leading venture capital and growth equity investment firm, announced today Zack Scott, M.D., has joined the investment team as general partner for the healthcare practice.
Dr. Scott joins Norwest from Revelation Partners, a dedicated secondary investor in the healthcare space, where he was a co-founder and managing partner.
"We're fortunate to have Zack join our team and contribute his years of experience in medical devices, diagnostics, healthcare services, and biopharmaceuticals to the firm and the portfolio," said Casper de Clercq, general partner, Norwest Venture Partners. "Through our shared investments in Omada Health and iRhythm Technologies, we know Zack has a similar investment thesis that is grounded in real-world evidence and improving patient outcomes."
"I was drawn to Norwest's healthcare team because I believe its diversified investment philosophy will make a lasting, positive impact on the future of healthcare," said Dr. Scott, general partner, Norwest Venture Partners. "I'm excited to join Norwest and help entrepreneurs bring to life their visions to improve healthcare outcomes for more people."
Prior to working in private equity, Dr. Scott was a General Surgery resident at Oregon Health & Science University in Portland, Oregon. He earned his M.D. from the University of Texas Health Science Center at San Antonio where he was a member of the AOA Medical Honors Society, and subsequently earned an M.B.A. with a specialized certificate in Health Sector Management from The Fuqua School of Business at Duke University where he was a Fuqua Scholar.
Earlier this year, Norwest welcomed Tiba Aynechi, Ph.D., as a general partner on the healthcare team to lead its biotech practice.
Norwest is a leading venture and growth equity investment firm managing more than $12.5 billion in capital. Since its inception, Norwest has invested in more than 650 companies and currently partners with more than 200 companies in its venture and growth equity portfolio. The firm invests in early- to late-stage businesses across a wide range of sectors with a focus on consumer, enterprise, and healthcare. The Norwest team offers a deep network of connections, operating experience, and a wide range of impactful services to help CEOs and founders scale their businesses. Norwest has offices in Palo Alto and San Francisco, with subsidiaries in India and Israel. For more information, please visit www.nvp.com. Follow Norwest on Twitter @NorwestVP.
All brands, names or trademarks mentioned in this document are the property of their respective owners.
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.